This table reports the results by model of care with each letter in the table representing one study, and indicating the study design and effect size where known.
Also, it is interesting to note that only approximately 40% of the connotations were positive, indicating the study sample may not consider hearing aids to be a very positive aspect of the society.
Each subject was randomized by dispensing the next sequentially numbered subject code and opening the corresponding code envelope indicating the study arm to be assigned to the participant in question.
The final grade indicating the study quality as a result of this systematic evaluation was based on the quality of data sources and methodology used, the risk of bias, and the consideration of co-factors.
Finally, the participation rate of eligible mothers in the VTS was extremely high, indicating the study participants are unlikely to differ substantially from the rest of the mothers in the DSS, whose children did not have the opportunity to receive vaccinations through VTS.
In the most extreme case evaluated, a design with ralt = 0.2, rnul = 0.05, ttpalt = 7, and ttpnul = 4 results in stage I rejection values of r1 ≤ -1 and epd ≥ 16, indicating the study is unable to reject Hnul at stage I and all trials will recruit 30 subjects.
